2012 looks a banner year for Teva's Copaxone

By NADAV NEUMAN
August 6, 2012 22:32

Expert: Company to report net profit of $4.74 billion this year.




Teva CEO JEREMY LEVIN

Teva CEO JEREMY LEVIN 370. (photo credit: Reuters)


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 8 - 20
    Beer Sheva
    10 - 19
    Tel Aviv - Yafo
  • 8 - 16
    Jerusalem
    10 - 18
    Haifa
  • 13 - 25
    Elat
    10 - 22
    Tiberias